PRKN and Parkinson disease: Since PARK2-mutated patients offer a unique pathological background in which PD pathology is driven by Parkin loss-of-function and PINK1/Parkin mitophagy impairment (Youle and Narendra, 2011), we decided to verify the whole-cell and mitochondrial quantitative proteomic alterations that characterize these PD patients.